BR9508053A - Construção de DNA vetor de expressão recombinante cepa de levedura e processo para a produção de uma proteina heteróloga - Google Patents
Construção de DNA vetor de expressão recombinante cepa de levedura e processo para a produção de uma proteina heterólogaInfo
- Publication number
- BR9508053A BR9508053A BR9508053A BR9508053A BR9508053A BR 9508053 A BR9508053 A BR 9508053A BR 9508053 A BR9508053 A BR 9508053A BR 9508053 A BR9508053 A BR 9508053A BR 9508053 A BR9508053 A BR 9508053A
- Authority
- BR
- Brazil
- Prior art keywords
- construction
- production
- heterologous protein
- yeast strain
- vector dna
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/62—Insulins
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/62—DNA sequences coding for fusion proteins
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/80—Vectors or expression systems specially adapted for eukaryotic hosts for fungi
- C12N15/81—Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
- C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DK71294 | 1994-06-17 | ||
PCT/DK1995/000250 WO1995035384A1 (en) | 1994-06-17 | 1995-06-16 | N-terminally extended proteins expressed in yeast |
Publications (1)
Publication Number | Publication Date |
---|---|
BR9508053A true BR9508053A (pt) | 1997-08-12 |
Family
ID=8096676
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR9508053A BR9508053A (pt) | 1994-06-17 | 1995-06-16 | Construção de DNA vetor de expressão recombinante cepa de levedura e processo para a produção de uma proteina heteróloga |
Country Status (16)
Country | Link |
---|---|
EP (1) | EP0765395A1 (fi) |
JP (1) | JP3730255B2 (fi) |
CN (1) | CN1131312C (fi) |
AU (1) | AU2733595A (fi) |
BR (1) | BR9508053A (fi) |
CA (1) | CA2192943A1 (fi) |
CZ (1) | CZ363796A3 (fi) |
FI (1) | FI965030A (fi) |
HU (1) | HUT75840A (fi) |
IL (1) | IL114160A (fi) |
MX (1) | MX9606536A (fi) |
NO (1) | NO965411L (fi) |
PL (1) | PL317761A1 (fi) |
SG (1) | SG47883A1 (fi) |
WO (1) | WO1995035384A1 (fi) |
ZA (1) | ZA954983B (fi) |
Families Citing this family (42)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6500645B1 (en) | 1994-06-17 | 2002-12-31 | Novo Nordisk A/S | N-terminally extended proteins expressed in yeast |
ZA9610456B (en) * | 1995-12-20 | 1997-06-20 | Novo Nordisk As | N-terminally extended proteins expressed in yeast |
DE69739319D1 (de) | 1996-12-13 | 2009-04-30 | Novartis Vaccines & Diagnostic | Verfahren zur Expression von PDGF oder IGR Proteinen in Hefe |
ES2258797T3 (es) * | 1996-12-20 | 2006-09-01 | Novo Nordisk A/S | Proteinas con extension n-terminal expresadas en la levadura. |
JP2003525570A (ja) * | 1998-01-23 | 2003-09-02 | ノボ ノルディスク アクティーゼルスカブ | 酵母において所望のポリペプチドを産生する方法 |
DE60044728D1 (de) | 1999-12-29 | 2010-09-02 | Novo Nordisk As | VERFAHREN ZUR HERSTELLUNG VON INSULINVORLäUFERN UND ANALOGEN VON INSULINVORLÄUFERN MIT VERBESSERTER FERMENTATIONSAUSBEUTE IN HEFE |
AU2002355160A1 (en) * | 2001-07-24 | 2003-02-17 | Novo Nordisk A/S | Method for making acylated polypeptides |
US7595172B2 (en) | 2001-07-24 | 2009-09-29 | Novo Nordisk A/S | Method for making acylated polypeptides |
US20030082671A1 (en) | 2001-07-24 | 2003-05-01 | Thomas Hoeg-Jensen | Method for making acylated polypeptides |
WO2004085472A1 (en) * | 2003-03-27 | 2004-10-07 | Novo Nordisk A/S | Method for making human insulin precursors and human insulin |
ES2369895T3 (es) | 2003-12-03 | 2011-12-07 | Novo Nordisk A/S | Insulina monocatenaria. |
CN102660614A (zh) | 2005-08-16 | 2012-09-12 | 诺沃-诺迪斯克有限公司 | 制备成熟胰岛素多肽的方法 |
ES2542146T3 (es) * | 2006-07-31 | 2015-07-31 | Novo Nordisk A/S | Insulinas extendidas PEGiladas. |
KR101699370B1 (ko) | 2006-09-22 | 2017-02-14 | 노보 노르디스크 에이/에스 | 프로테아제 내성 인슐린 유사체 |
EP2069502B1 (en) | 2006-09-27 | 2014-02-26 | Novo Nordisk A/S | Method for making maturated insulin polypeptides |
EP2084179B1 (en) | 2006-11-22 | 2013-05-22 | Novo Nordisk A/S | Method for making activated carboxypeptidases |
CN101743252A (zh) | 2007-07-16 | 2010-06-16 | 诺沃-诺迪斯克有限公司 | 蛋白酶稳定化的、peg化的胰岛素类似物 |
WO2009021955A1 (en) | 2007-08-13 | 2009-02-19 | Novo Nordisk A/S | Rapid acting insulin analogues |
ES2526924T3 (es) | 2007-08-15 | 2015-01-16 | Novo Nordisk A/S | Insulinas con una fracción acilo que comprende unidades repetitivas de aminoácidos que contienen alquilenglicol |
EP2178912B1 (en) | 2007-08-15 | 2015-07-08 | Novo Nordisk A/S | Insulin analogues with an acyl and aklylene glycol moiety |
WO2009115469A1 (en) | 2008-03-18 | 2009-09-24 | Novo Nordisk A/S | Protease stabilized, acylated insulin analogues |
ES2563553T3 (es) | 2008-04-01 | 2016-03-15 | Novo Nordisk A/S | Conjugados de insulina-albúmina |
CA2764423A1 (en) | 2009-06-26 | 2010-12-29 | Novo Nordisk A/S | Preparation comprising insulin, nicotinamide and an amino acid |
EP2504355B1 (en) | 2009-11-25 | 2015-07-22 | Novo Nordisk A/S | Method for making polypeptides |
WO2011161124A1 (en) | 2010-06-23 | 2011-12-29 | Novo Nordisk A/S | Insulin analogues containing additional disulfide bonds |
US8883722B2 (en) | 2010-06-23 | 2014-11-11 | Novo Nordisk A/S | Human insulin containing additional disulfide bonds |
CA2802510A1 (en) | 2010-06-23 | 2011-12-29 | Novo Nordisk A/S | Insulin derivatives containing additional disulfide bonds |
US20130331320A1 (en) | 2010-12-14 | 2013-12-12 | Novo Nordisk A/S | Fast-acting insulin in combination with long-acting insulin |
MX2013006174A (es) | 2010-12-14 | 2013-07-15 | Novo Nordisk As | Preparacion que comprende insulina, nicotinamida y un aminoacido. |
WO2012171994A1 (en) | 2011-06-15 | 2012-12-20 | Novo Nordisk A/S | Multi substituted insulins |
WO2013186138A1 (en) | 2012-06-14 | 2013-12-19 | Novo Nordisk A/S | Preparation comprising insulin, nicotinamide and arginine |
CA2890048C (en) | 2012-12-03 | 2022-05-03 | Merck Sharp & Dohme Corp. | O-glycosylated carboxy terminal portion (ctp) peptide-based insulin and insulin analogues |
EP3004156A1 (en) | 2013-06-07 | 2016-04-13 | Novo Nordisk A/S | Method for making mature insulin polypeptides |
JP6983075B2 (ja) | 2015-06-02 | 2021-12-17 | ノヴォ ノルディスク アー/エス | 極性の組換え延長部を有するインスリン |
JP2018531900A (ja) | 2015-08-25 | 2018-11-01 | ノヴォ ノルディスク アー/エス | 新規インスリン誘導体及びその医学的使用 |
JP2018531899A (ja) | 2015-08-25 | 2018-11-01 | ノヴォ ノルディスク アー/エス | 新規インスリン誘導体及びその医学的使用 |
CN108026156A (zh) | 2015-08-25 | 2018-05-11 | 诺和诺德股份有限公司 | 新型胰岛素衍生物及其医学用途 |
BR112018072034A2 (pt) * | 2016-05-24 | 2019-02-12 | Novo Nordisk A/S | compostos mic-1 e usos dos mesmos |
EP3668892A1 (en) | 2017-08-17 | 2020-06-24 | Novo Nordisk A/S | Novel acylated insulin analogues and uses thereof |
EP3807306A4 (en) * | 2018-06-18 | 2022-04-06 | Unichem Laboratories Limited | LEADER SEQUENCE FOR HIGHER EXPRESSION OF RECOMBINANT PROTEINS |
CN114787184A (zh) | 2019-12-11 | 2022-07-22 | 诺和诺德股份有限公司 | 新型胰岛素类似物及其用途 |
WO2023144240A1 (en) | 2022-01-26 | 2023-08-03 | Novo Nordisk Research Centre Oxford Limited | Glucose sensitive insulin derivatives and uses thereof |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2593518B1 (fr) * | 1985-05-02 | 1989-09-08 | Transgene Sa | Vecteurs d'expression et de secretion de l'hirudine par les levures transformees |
US5010182A (en) * | 1987-07-28 | 1991-04-23 | Chiron Corporation | DNA constructs containing a Kluyveromyces alpha factor leader sequence for directing secretion of heterologous polypeptides |
CA1340772C (en) * | 1987-12-30 | 1999-09-28 | Patricia Tekamp-Olson | Expression and secretion of heterologous protiens in yeast employing truncated alpha-factor leader sequences |
DK105489D0 (da) * | 1989-03-03 | 1989-03-03 | Novo Nordisk As | Polypeptid |
DK300090D0 (da) * | 1990-12-19 | 1990-12-19 | Novo Nordisk As | Fremgangsmaade til fremstilling af leadersekvenser |
WO1992013951A1 (en) * | 1991-02-04 | 1992-08-20 | The Salk Institute Biotechnology/Industrial Associates, Inc. | Production of human serum albumin in methylotrophic yeast cells |
-
1995
- 1995-06-15 IL IL114160A patent/IL114160A/en not_active IP Right Cessation
- 1995-06-15 ZA ZA954983A patent/ZA954983B/xx unknown
- 1995-06-16 JP JP50150596A patent/JP3730255B2/ja not_active Expired - Lifetime
- 1995-06-16 BR BR9508053A patent/BR9508053A/pt not_active Application Discontinuation
- 1995-06-16 AU AU27335/95A patent/AU2733595A/en not_active Abandoned
- 1995-06-16 MX MX9606536A patent/MX9606536A/es unknown
- 1995-06-16 HU HU9603476A patent/HUT75840A/hu unknown
- 1995-06-16 EP EP95922440A patent/EP0765395A1/en not_active Ceased
- 1995-06-16 CZ CZ963637A patent/CZ363796A3/cs unknown
- 1995-06-16 WO PCT/DK1995/000250 patent/WO1995035384A1/en not_active Application Discontinuation
- 1995-06-16 CA CA002192943A patent/CA2192943A1/en not_active Abandoned
- 1995-06-16 CN CN95194181A patent/CN1131312C/zh not_active Expired - Lifetime
- 1995-06-16 PL PL95317761A patent/PL317761A1/xx unknown
- 1995-09-16 SG SG1996004970A patent/SG47883A1/en unknown
-
1996
- 1996-12-16 NO NO965411A patent/NO965411L/no unknown
- 1996-12-16 FI FI965030A patent/FI965030A/fi unknown
Also Published As
Publication number | Publication date |
---|---|
PL317761A1 (en) | 1997-04-28 |
FI965030A0 (fi) | 1996-12-16 |
CA2192943A1 (en) | 1995-12-28 |
FI965030A (fi) | 1997-02-14 |
CN1152942A (zh) | 1997-06-25 |
JPH10501695A (ja) | 1998-02-17 |
HUT75840A (en) | 1997-05-28 |
ZA954983B (en) | 1996-02-14 |
IL114160A (en) | 2006-12-31 |
MX9606536A (es) | 1997-03-29 |
HU9603476D0 (en) | 1997-02-28 |
JP3730255B2 (ja) | 2005-12-21 |
CZ363796A3 (en) | 1997-05-14 |
CN1131312C (zh) | 2003-12-17 |
NO965411D0 (no) | 1996-12-16 |
WO1995035384A1 (en) | 1995-12-28 |
IL114160A0 (en) | 1995-10-31 |
SG47883A1 (en) | 1998-04-17 |
AU2733595A (en) | 1996-01-15 |
EP0765395A1 (en) | 1997-04-02 |
NO965411L (no) | 1997-02-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR9508053A (pt) | Construção de DNA vetor de expressão recombinante cepa de levedura e processo para a produção de uma proteina heteróloga | |
FI973055A (fi) | Soluja yhdistelmä-DNA-adenovirusten tuottamiseksi | |
BRPI9801092B1 (pt) | processo para a produÇço de fator recombinante viii e meio de cultura de cÉlula. | |
DE69611102T2 (de) | Verstärkung der mutagenese von nukleinsäuren | |
BR9403442A (pt) | Silanos, processo para sua produção e aplicação dos ditos silanos | |
BR8101972A (pt) | Vetor, processo para sua producao, processo para produzir uma molecula recombinante de dna, e processo para produzir um polipeptideo | |
BR9606453A (pt) | Microválvula e processo para a fabricação de uma microválvula | |
EE9700137A (et) | Peptiidide ja proteiinide aerosoolvormid | |
BR9601256A (pt) | Processo para a fragmentação de material de minério | |
BR9509890A (pt) | Polipeptídeo sequencia de dna ou rna vetor célula hospedeira e processo para produzir um polipeptídeo | |
NO971875D0 (no) | Cathepsin 02 protease | |
BR9709733A (pt) | Construção de dna quimérico recominante e processo para seleção de linhagens | |
BR9101137A (pt) | Metodo para a preparacao de um vetor hibrido,processo para a preparacao de uma molecula de dna,metodo para a preparacao de um hospedeiro e para a preparacao de um polipeptidio e metodo para a preparacao de psm puro | |
EE200000152A (et) | Aminoterminaalselt kärbitud MCP-2 vormid, DNA molekulid, ekspressioonivektor, peremeesrakk, rekombinantne meetod proteiini valmistamiseks, proteiini kasutamine ning farmatseutiline kompositsioon | |
BR9508714A (pt) | Composto processo de preparação de estreptogramas por muta-síntese sequencia nucleotídica dna recombinante vetor utilização de uma sequencia e/ou de um vetor polipetídeo cepa mutante e composição farmacèutica | |
ITMI951764A0 (it) | Peptide sintetasi ingegnerizzate e loro impiego per la produzione via non-ribosomale di peptidi | |
BRPI9600729B8 (pt) | vetor de expressão, microorganismo transgênico, processo de clonagem de um ácido nucléico e processo para preparação de uma proteína e cepa de levedura transformada | |
GB9724879D0 (en) | Process for the production of protein and products thereof | |
BR9606270A (pt) | Processo para a produção da proteína do interferon beta-cis humano recombinante e proteína de interferon beta-cis humano recombinante | |
AU3131195A (en) | Vectors and transformed host cells for recombinant protein production at reduced temperatures | |
PT789767E (pt) | Processo para a producao de proteinas de papilomavirus purificadas | |
EP1028095A4 (en) | REINFORCEMENT MATERIAL, ASSOCIATED PRODUCTION METHOD, REINFORCEMENT / REPAIR METHOD USING THE SAME, REINFORCEMENT / REPAIR STRUCTURE, AND STRUCTURAL ELEMENT | |
AU5635896A (en) | Recombinant endotoxin-neutralizing proteins | |
ATE316138T1 (de) | Rekombinante expression von s-layer-proteinen | |
BR9306150A (pt) | Endo--1,4-glucanase sequéncia de dna recombinante vetor hospedeiro transformado contendo o vetor processo para a produç o de endo- -1,4-glucanase preparaç o de enzima e uso de endo- -1,4-glucanase |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA10 | Dismissal: dismissal - article 33 of industrial property law |